Fibroblast growth factor

From Wikipedia, the free encyclopedia - View original article

Fibroblast growth factor
Crystal Structure of FGF10-FGFR2b Complex-1NUN.png
Crystal structure analysis of the FGF10-FGFR2b complex
Identifiers
SymbolFGF
PfamPF00167
Pfam clanCL0066
InterProIPR002348
PROSITEPDOC00220
SCOP1bas
SUPERFAMILY1bas
 
Jump to: navigation, search
Fibroblast growth factor
Crystal Structure of FGF10-FGFR2b Complex-1NUN.png
Crystal structure analysis of the FGF10-FGFR2b complex
Identifiers
SymbolFGF
PfamPF00167
Pfam clanCL0066
InterProIPR002348
PROSITEPDOC00220
SCOP1bas
SUPERFAMILY1bas

Fibroblast growth factors, or FGFs, are a family of growth factors, with members involved in angiogenesis, wound healing, embryonic development and various endocrine signaling pathways. The FGFs are heparin-binding proteins and interactions with cell-surface-associated heparan sulfate proteoglycans have been shown to be essential for FGF signal transduction. FGFs are key players in the processes of proliferation and differentiation of wide variety of cells and tissues.

Families[edit]

In humans, 22 members of the FGF family have been identified, all of which are structurally related signaling molecules:[1][2][3]

Receptors[edit]

The mammalian fibroblast growth factor receptor family has 4 members, FGFR1, FGFR2, FGFR3, and FGFR4. The FGFRs consist of three extracellular immunoglobulin-type domains (D1-D3), a single-span trans-membrane domain and an intracellular split tyrosine kinase domain. FGFs interact with the D2 and D3 domains, with the D3 interactions primarily responsible for ligand-binding specificity (see below). Heparan sulfate binding is mediated through the D3 domain. A short stretch of acidic amino acids located between the D1 and D2 domains has auto-inhibitory functions. This 'acid box' motif interacts with the heparan sulfate binding site to prevent receptor activation in the absence of FGFs.

Alternate mRNA splicing gives rise to 'b' and 'c' variants of FGFRs 1, 2 and 3. Through this mechanism seven different signaling FGFR sub-types can be expressed at the cell surface. Each FGFR binds to a specific subset of the FGFs. Similarly most FGFs can bind to several different FGFR subtypes. FGF1 is sometimes referred to as the 'universal ligand' as it is capable of activating all 7 different FGFRs. In contrast, FGF7 (keratinocyte growth factor, KGF) binds only to FGFR2b (KGFR).

The signaling complex at the cell surface is believed to be a ternary complex formed between two identical FGF ligands, two identical FGFR subunits, and either one or two heparan sulfate chains.

History[edit]

Fibroblast growth factor was found in pituitary extracts by Armelin in 1973[11] and then was also found in a cow brain extract by Gospodarowicz, et al., and tested in a bioassay that caused fibroblasts to proliferate (first published report in 1974).[12]

They then further fractionated the extract using acidic and basic pH and isolated two slightly different forms that were named "acidic fibroblast growth factor" (FGF1) and "basic fibroblast growth factor" (FGF2). These proteins had a high degree of amino acid identity but were determined to be distinct mitogens. Human FGF2 occurs in low molecular weight (LMW) and high molecular weight (HMW) isoforms.[13] LMW FGF2 is primarily cytoplasmic and functions in an autocrine manner, whereas HMW FGF2s are nuclear and exert activities through an intracrine mechanism.

Not long after FGF1 and FGF2 were isolated, another group isolated a pair of heparin-binding growth factors that they named HBGF-1 and HBGF-2, while a third group isolated a pair of growth factors that caused proliferation of cells in a bioassay containing blood vessel endothelium cells, which they called ECGF1 and ECGF2. These proteins were found to be identical to the acidic and basic FGFs described by Gospodarowicz, et al.

Functions[edit]

FGFs are multifunctional proteins with a wide variety of effects; they are most commonly mitogens but also have regulatory, morphological, and endocrine effects. They have been alternately referred to as "pluripotent" growth factors and as "promiscuous" growth factors due to their multiple actions on multiple cell types.[14][15] Promiscuous refers to the biochemistry and pharmacology concept of how a variety of molecules can bind to and elicit a response from single receptor. In the case of FGF, four receptor subtypes can be activated by more than twenty different FGF ligands. Thus the functions of FGFs in developmental processes include mesoderm induction, antero-posterior patterning,[7] limb development, neural induction and neural development,[16] and in mature tissues/systems angiogenesis, keratinocyte organization, and wound healing processes.

FGF is critical during normal development of both vertebrates and invertebrates and any irregularities in their function leads to a range of developmental defects.[17][18][19][20]

FGFs secreted by hypoblasts during avian gastrulation play a role in stimulating a Wnt signaling pathway that is involved in the differential movement of Koller's sickle cells during formation of the primitive streak.[21]

FGF-1-induced angiogenesis in a human heart muscle. Left, angiography of the newly formed vascular network in the region of the front wall of the left ventricle. Right, analysis quantifying the angiogenic effect.[22]

One important function of FGF1 and FGF2 is the promotion of endothelial cell proliferation and the physical organization of endothelial cells into tube-like structures. They thus promote angiogenesis, the growth of new blood vessels from the pre-existing vasculature. FGF1 and FGF2 are more potent angiogenic factors than vascular endothelial growth factor (VEGF) or platelet-derived growth factor (PDGF).[23] FGF1 has been shown in clinical experimental studies to induce angiogenesis in the heart.[22]

As well as stimulating blood vessel growth, FGFs are important players in wound healing. FGF1 and FGF2 stimulate angiogenesis and the proliferation of fibroblasts that give rise to granulation tissue, which fills up a wound space/cavity early in the wound-healing process. FGF7 and FGF10 (also known as Keratinocyte Growth Factors KGF and KGF2, respectively) stimulate the repair of injured skin and mucosal tissues by stimulating the proliferation, migration and differentiation of epithelial cells, and they have direct chemotactic effects on tissue remodeling.

During development of the central nervous system, FGFs play important roles in neurogenesis, axon growth, and differentiation. FGFs are also important for maintenance of the adult brain. Thus, FGFs are major determinants of neuronal survival both during development and during adulthood.[24] Adult neurogenesis within the hippocampus e.g. depends greatly on FGF-2. In addition, FGF-1 and FGF-2 seem to be involved in the regulation of synaptic plasticity and processes attributed to learning and memory, at least in the hippocampus.[25]

Most FGFs are secreted proteins that bind heparan sulfates and can, therefore, be caught up in the extracellular matrix of tissues that contain heparan sulfate proteoglycans. This local action of FGF proteins is classified as paracrine signalling, most commonly through the JAK-STAT signaling pathway or the Receptor tyrosine kinase (RTK) pathway.

Members of the FGF19 subfamily (FGF15, FGF19, FGF21, and FGF23) bind less tightly to heparan sulfates, and so can act in an endocrine fashion on far-away tissues, such as intestine, liver, kidney, adipose, and bone.[9] For example:

Structure[edit]

The crystal structures of HBGF1 have been solved and found to be related to interleukin 1-beta. Both families have the same 12-stranded beta-sheet structure, and the beta-sheets are arranged in 3 similar lobes around a central axis, 6 strands forming an anti-parallel beta-barrel.[28][29][30] In general, the beta-sheets are well-preserved and the crystal structures superimpose in these areas. The intervening loops are less well-conserved - the loop between beta-strands 6 and 7 is slightly longer in interleukin-1 beta.

See also[edit]

References[edit]

  1. ^ Finklestein S.P., Plomaritoglou A. (2001). "Growth factors". In Miller L.P., Hayes R.L., eds. Co-edited by Newcomb J.K. Head Trauma: Basic, Preclinical, and Clinical Directions. New York: Wiley. pp. 165–187. ISBN 0-471-36015-5. 
  2. ^ Blaber M, DiSalvo J, Thomas KA (February 1996). "X-ray crystal structure of human acidic fibroblast growth factor". Biochemistry 35 (7): 2086–94. doi:10.1021/bi9521755. PMID 8652550. 
  3. ^ Ornitz DM, Itoh N (2001). "Fibroblast growth factors". Genome Biol. 2 (3): reviews3005.1–reviews3005.12. doi:10.1186/gb-2001-2-3-reviews3005. PMC 138918. PMID 11276432. 
  4. ^ Olsen SK, Garbi M. et al. (2003). "Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs". J. Biol. Chem. 278 (36): 34226–36. doi:10.1074/jbc.M303183200. PMID 12815063. 
  5. ^ Itoh N, Ornitz DM (January 2008). "Functional evolutionary history of the mouse Fgf gene family". Dev. Dyn. 237 (1): 18–27. doi:10.1002/dvdy.21388. PMID 18058912. 
  6. ^ Moore, E.; Bendele, A.; Thompson, D.; Littau, A.; Waggie, K.; Reardon, B.; Ellsworth, J. (2005). "Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis". Osteoarthritis and Cartilage 13 (7): 623–631. doi:10.1016/j.joca.2005.03.003. PMID 15896984.  edit
  7. ^ a b Koga C, Adati N, Nakata K, Mikoshiba K, Furuhata Y, Sato S, Tei H, Sakaki Y, Kurokawa T (August 1999). "Characterization of a novel member of the FGF family, XFGF-20, in Xenopus laevis". Biochemical and Biophysical Research Communications 261 (3): 756–65. doi:10.1006/bbrc.1999.1039. PMID 10441498. 
  8. ^ Kirikoshi H, Sagara N, Saitoh T, Tanaka K, Sekihara H, Shiokawa K, Katoh M (August 2000). "Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22". Biochemical and Biophysical Research Communications 274 (2): 337–43. doi:10.1006/bbrc.2000.3142. PMID 10913340. 
  9. ^ a b c Potthoff, M. J.; Kliewer, S. A.; Mangelsdorf, D. J. (2 February 2012). "Endocrine fibroblast growth factors 15/19 and 21: from feast to famine". Genes & Development 26 (4): 312–324. doi:10.1101/gad.184788.111. PMC 3289879. PMID 22302876. 
  10. ^ Fukumoto S (2008). "Actions and mode of actions of FGF19 subfamily members". Endocr. J. 55 (1): 23–31. doi:10.1507/endocrj.KR07E-002. PMID 17878606. 
  11. ^ Armelin HA (September 1973). "Pituitary extracts and steroid hormones in the control of 3T3 cell growth". Proc. Natl. Acad. Sci. U.S.A. 70 (9): 2702–6. Bibcode:1973PNAS...70.2702A. doi:10.1073/pnas.70.9.2702. PMC 427087. PMID 4354860. 
  12. ^ Gospodarowicz D (1974). "Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth". Nature 249 (453): 123–7. Bibcode:1974Natur.249..123G. doi:10.1038/249123a0. PMID 4364816. 
  13. ^ Arese M, Chen Y., et al. (1999). "Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals". Mol. Biol. Cell 10 (5): 1429–44. doi:10.1091/mbc.10.5.1429. PMC 25296. PMID 10233154. 
  14. ^ Vlodavsky I, Korner G, Ishai-Michaeli R, Bashkin P, Bar-Shavit R, Fuks Z (1990). "Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis". Cancer Metastasis Rev 9 (3): 203–26. doi:10.1007/BF00046361. PMID 1705486. 
  15. ^ Green PJ, Walsh FS, Doherty P (1996). "Promiscuity of fibroblast growth factor receptors". BioEssays 18 (8): 639–46. doi:10.1002/bies.950180807. PMID 8760337. 
  16. ^ Böttcher RT, Niehrs C. (2005). "Fibroblast growth factor signaling during early vertebrate development". Endocr. Rev. 26 (1): 63–77. doi:10.1210/er.2003-0040. PMID 15689573. 
  17. ^ Amaya E, Musci T.J. and Kirschner M.W. (1991). "Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos". Cell 66 (2): 257–270. doi:10.1016/0092-8674(91)90616-7. PMID 1649700. 
  18. ^ Borland C.Z., Schutzman J.L. and Stern M.J. (2001). "Fibroblast growth factor signaling in Caenorhabditis elegans". BioEssays 23 (12): 1120–1130. doi:10.1002/bies.10007. PMID 11746231. 
  19. ^ Coumoul X. and Deng C.X. (2003). "Roles of FGF receptors in mammalian development and congenital diseases". Birth Defects Res C Embryo Today 69 (4): 286–304. doi:10.1002/bdrc.10025. PMID 14745970. 
  20. ^ Sutherland D, Samakovlis C . and Krasnow M.A. (1996). "Branchless encodes a Drosophila FGF homolog that controls tracheal cell migration and the pattern of branching". Cell 87 (6): 1091–1101. doi:10.1016/S0092-8674(00)81803-6. PMID 8978613. 
  21. ^ Gilbert SF. Developmental Biology. 10th edition. Sunderland (MA): Sinauer Associates; 2014. Early Development in Birds. Print
  22. ^ a b Stegmann, TJ (May 1999). "New approaches to coronary heart disease: induction of neovascularisation by growth factors". BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 11 (5): 301–8. doi:10.2165/00063030-199911050-00002. PMID 18031140. 
  23. ^ Vlodavsky Cao R, Bråkenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y (2003). "Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2". Nature Medicine 9 (5): 604–13. doi:10.1038/nm848. PMID 12669032. 
  24. ^ Reuss, B.; von Bohlen und Halbach, O. (2003). "Fibroblast growth factors and their receptors in the central nervous system". Cell and Tissue Research 313 (2): 139–157. doi:10.1007/s00441-003-0756-7. PMID 12845521.   edit
  25. ^ Zechel, S.; Werner, S.; Unsicker, K.; Von Bohlen und Halbach, O. (2010). "Expression and Functions of Fibroblast Growth Factor 2 (FGF-2) in Hippocampal Formation". The Neuroscientist 16 (4): 357–373. doi:10.1177/1073858410371513. PMID 20581332.  edit
  26. ^ Jones, SA (2012). "Physiology of FGF15/19". Advances in experimental medicine and biology. Advances in Experimental Medicine and Biology 728: 171–82. doi:10.1007/978-1-4614-0887-1_11. ISBN 978-1-4614-0886-4. PMID 22396169. 
  27. ^ Razzaque, MS (November 2009). "The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis". Nature Reviews Endocrinology 5 (11): 611–9. doi:10.1038/nrendo.2009.196. PMC 3107967. PMID 19844248. 
  28. ^ Murzin AG, Lesk AM, Chothia C (January 1992). "beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors". J. Mol. Biol. 223 (2): 531–43. doi:10.1016/0022-2836(92)90668-A. PMID 1738162. 
  29. ^ Eriksson AE, Cousens LS, Weaver LH, Matthews BW (April 1991). "Three-dimensional structure of human basic fibroblast growth factor". Proc. Natl. Acad. Sci. U.S.A. 88 (8): 3441–5. Bibcode:1991PNAS...88.3441E. doi:10.1073/pnas.88.8.3441. PMC 51463. PMID 1707542. 
  30. ^ Gimenez-Gallego G, Rodkey J, Bennett C, Rios-Candelore M, DiSalvo J, Thomas K (December 1985). "Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies". Science 230 (4732): 1385–8. Bibcode:1985Sci...230.1385G. doi:10.1126/science.4071057. PMID 4071057. 

External links[edit]

This article incorporates text from the public domain Pfam and InterPro IPR002348